Pyrrhocoricin [L7R, R14K]

General Information


DRACP ID  DRACP02688

Peptide Name   Pyrrhocoricin [L7R, R14K]

Sequence  VDKGSYRPRPTPPKPIYNRN

Sequence Length  20

UniProt ID  P37362 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A431 Skin squamous cell carcinoma Carcinoma <10% Cytotoxicity=10 µM MTT assay 24 h 1
MDA-MB-231 Breast adenocarcinoma Carcinoma Not active up to 10 µM MTT assay 24 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02688

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C105H167N33O29

Absent amino acids  ACEFHLMQW

Common amino acids  P

Mass  269473

Pl  10.95

Basic residues  5

Acidic residues  1

Hydrophobic residues  2

Net charge  4

Boman Index  -7421

Hydrophobicity  -178

Aliphatic Index  34

Half Life 
  Mammalian: 100 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  2980

Absorbance 280nm  156.84

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31209863

Title  Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery

Doi 10.1002/bit.27092

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_13550

DRACP is developed by Dr.Zheng's team.